Pericardiocentesis

Published on 21/06/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1930 times

18 Pericardiocentesis

Cardiac tamponade is a life-threatening disorder that can result from any condition that causes a pericardial effusion. Although the most frequent cause is malignancy, tamponade may also occur from pericarditis (e.g., viral, uremic, inflammatory, or idiopathic), aortic dissection (with disruption of the aortic annulus), or ventricular rupture from myocardial infarction. In the cardiac catheterization laboratory, tamponade can result as a complication of a variety of invasive procedures and lead to rapid demise of the patient due to the swift accumulation of fluid in a poorly compliant pericardial space. Prompt recognition of the salient hemodynamic features and immediate pericardiocentesis are essential to the successful treatment of cardiac tamponade. The rate of pericardial fluid accumulation relative to the stiffness of the pericardium determines how quickly the clinical syndrome of tamponade will occur. Figure 18-1 shows a normal pericardial membrane and the mechanisms of pericardial tamponade.

Diagnosis of Tamponade

The hemodynamic effects of a pericardial effusion may be acute or gradual, depending on the amount and rate of fluid accumulation. Normally, the pericardial space contains 15 to 50mL of fluid with an intrapericardial pressure that approximates intrapleural pressure (−5 to +5cm H2O). Fluid accumulation and pericardial restraint lead to rises in intrapericardial pressure. Tamponade occurs when intrapericardial pressure exceeds intracardiac pressure, leading to impaired ventricular filling, increases in pulmonary venous and jugular venous pressures, and reduction in forward stroke volume. During interventional procedures, tamponade may be signaled by hypotension. Tachycardia, which usually occurs, may not be present in patients receiving beta blockers. A high index of suspicion of tamponade should accompany any procedure in which a distal guidewire position appears unusual or in which oversized stents are used. All procedures with rotational atherectomy have a higher incidence of perforation and subsequent tamponade.

Hemodynamics

The invasive hemodynamic hallmarks of cardiac tamponade include pulsus paradoxus on the arterial tracing (Fig. 18-3) and prominent x descents and blunted y descents in the atrial pressure tracings (Fig. 18-4). Preservation of the x descent occurs because of the decrease in intracardiac volume during systolic ejection, which leads to a temporary reduction in intrapericardial and right atrial pressures (See Kern (2011) The Cardiac Catheterization Handbook 5th ed., Chapter 3 Hemodynamics). Elevated intrapericardial pressure impairs ventricular filling during the remainder of the cardiac cycle, resulting in blunting of the y descent. In patients with cardiac tamponade, the driving pressure to fill the left ventricle falls during inspiration. Consequently, there is a reduction in left ventricular filling and stroke volume, which manifests as a decrease in aortic pulse pressure during inspiration in a manner analogous to the bedside finding of pulsus paradoxus (see Fig. 18-3).

On relief of pericardial pressure and removal of the effusion, right atrial pressure and pericardial pressure fall usually to normal values if no residual pericardial disease is present (Fig. 18-5). However, in some cases, although pericardiocentesis empties the pericardial space and pericardial pressure falls to near zero, right atrial pressure may be unaffected, signifying the syndrome of effusive-constrictive pericardial disease (Fig. 18-6).

Cardiac tamponade should be suspected in any patient in the cardiac catheterization laboratory with unexplained hypotension, elevated venous pressure, and a compatible history. Unusual manifestations also can occur. Tamponade may occur without elevated jugular venous pressure because of low intracardiac filling pressures (i.e., low-pressure tamponade), such as in dehydrated patients with malignant effusions. Localized tamponade can result from loculated pericardial effusions, such as those that may be present adjacent to the atria in the postoperative setting. Of note, pericardiocentesis should not be performed in patients with tamponade and aortic dissection. In such patients, relief of the tamponade will lead to an abrupt increase in systolic blood pressure that may exacerbate the aortic dissection. Careful imaging with transthoracic or transesophageal echocardiography is required to determine the presence of these manifestations of tamponade.

Technique for Pericardiocentesis

The basic technique of pericardiocentesis is discussed in Table 18-1 lists the equipment used for the procedure. For most patients, pericardiocentesis is performed with echocardiographic guidance. In some cases, additional use of hemodynamic monitoring through the pericardial needle adds important information during both puncture and after withdrawal of fluid to verify procedural findings. Certainly, in emergent situations where echocardiography is not immediately available, pericardiocentesis can be performed in a blinded or electrocardiogram (ECG)-guided fashion, usually from the subxiphoid approach. However, adjunctive echocardiography plays a significant role in the evaluation of patients with cardiac tamponade and will reduce the incidence of complications related to pericardiocentesis. Figure 18-7 shows several points of pericardial access.

Table 18-1 Equipment for Pericardiocentesis

Sterile gloves, mask, and gown
Povidone-iodine solution or other skin antiseptic
Sterile transparent plastic drape
20- or 25-gauge needle for local anesthesia administration
Local anesthesia (e.g., 1% lidocaine)
18-gauge polytef-sheathed venous needles of varying lengths (5–8 cm)
Syringes (10 mL, 20 mL, and 50 mL)
0.035-inch J-tipped guidewire
Scalpel (no. 11 blade)
5F or 6F introducer sheath
5F or 6F 65-cm pigtail catheter with multiple side holes
4 × 4 inch gauze for dressing and ointment
1-L vacuum bottle or comparable fluid receptacle
Labels for specimen collection
Sterile isotonic saline (for catheter flush)

For all patients, volume resuscitation can help provide hemodynamic stability and should be performed in patients with cardiac tamponade. Reversal of anticoagulation and antiplatelet therapy should be performed as clinically permitted. During pericardiocentesis, right heart catheterization with simultaneous measurement of right atrial and pulmonary capillary wedge pressures assist in the diagnosis and for determining efficacy of the procedure.

Patient positioning. The patient usually is positioned with head raised approximately 30 degrees to facilitate inferior and apical pooling of the pericardial effusion.

Site of entry. Echocardiography helps to determine the most appropriate site of entry and needle direction. Most frequently, the echocardiographic window that is closest to the effusion is selected. Common portals of entry are subxiphoid and apical, but other locations have included axillary, and left or right parasternal (see Fig. 18-7). Advantages of the subxiphoid approach are a lower risk of pneumothorax and laceration of internal mammary or intercostal arteries. For the subxiphoid approach, the needle must be angled clear below the bottom rib as it attaches to the inferolateral surface above the xiphoid process (typically one fingerbreadth inferior and lateral to the edge of the xiphoid).Punctures that are too high and near the recess at the xiphoid angle can pose challenges to delivering the needle under the rib. When using a parasternal approach, the needle should pass 1 cm lateral to the sternum to avoid injury to the internal mammary artery; the risk of pneumothorax increases with further lateral positioning. For intercostal approaches, the needle should pass superior to the rib margins to reduce the risk of injury to the neurovascular bundle. The angle of entry and direction should be transfixed in the operator’s mind. The site of entry can be marked with an indelible pen. The precordial or subxiphoid area is sterilized with antiseptic solution and covered with a sterile drape.

Needle insertion. Following local anesthesia, an 18-gauge, thin-walled polytef-sheathed needle is inserted at the entry site using the predetermined angulation. The needle is advanced with gentle aspiration into the pericardial space. Aggressive aspiration may cause tissue occlusion of the needle and inhibit detection of pericardial fluid. Once fluid has been obtained, the needle is advanced slightly further (~2 mm) to ensure placement of the sheath into the pericardial space. Figure 18-8 shows a pericardial needle and stopcock arrangement designed to check pericardial pressure and then aspirate pericardial fluid and discharge the fluid into a pericardial drainage bag. Alternately, a needle and sheath system can be used. Once the needle is in the pericardial space, the polytef sheath then is advanced over the needle, followed by withdrawal of the needle. The needle should not be re-advanced once it has been removed from the sheath.

Confirmation of location. Agitated saline is injected into the sheath via a three-way stopcock with echocardiographic imaging (Fig. 18-9). If the agitated saline does not enhance the pericardial space, then repositioning of the needle by either withdrawal or another needle passage is performed. Radiographic contrast can also be administered under fluoroscopy. Small test injections should be given initially to exclude myocardial positioning, which is seen as myocardial staining. Contrast swirling will indicate a ventricular location, while pooling suggests intrapericardial positioning. Alternatively, the needle (before it is withdrawn) or the sheath can be connected to tubing connectors for pressure transduction. Intrapericardial pressure will be similar to the atrial pressure, while ventricular systolic pressure waveforms can immediately alert the operator to inadvertent ventricular perforation. For operators using an ECG-guided approach, the needle is connected to an alligator-tipped electrode. With myocardial contact, ST-segment elevation (i.e., injury current) will be detected that may not appear on other electrocardiographic leads (Fig. 18-10).

Catheter placement. Following confirmation of position, a J-tipped guidewire is inserted through the polytef sheath into the pericardial space. A small skin incision with a scalpel is made, followed by exchange for a 5F or 6F introducer sheath and removal of the dilator. A multihole pigtail catheter is then inserted, followed by removal of the introducer sheath, leaving only the smooth-walled pigtail catheter in place. Positioning of the pigtail catheter can be reconfirmed using either echocardiography or pressure measurement.

Aspiration. Manual techniques or vacuum bottle can be used to remove the pericardial effusion. For patients with tamponade due to cardiac perforation, care should be taken to remove as much pericardial fluid as possible as this will facilitate sealing of the perforated site. For patients with other causes of pericardial effusion, complete apposition of the parietal and visceral layers also will reduce risk of recurrence. Inability to aspirate despite a persistent pericardial effusion on echocardiography should lead to repositioning of the pigtail catheter. Occasionally, puncture of a tense pericardium will lead to discharge of pericardial contents into a pleural space, resulting in less than expected removal via aspiration. Normalization of atrial pressures documented with simultaneous right heart catheterization helps to ensure successful removal of the pericardial effusion and relief of cardiac tamponade. For patients with large volume removal due to acute hemorrhage, cell savers often are used to minimize blood loss.

Post-pericardiocentesis management. The pigtail catheter is sutured to the chest wall, connected to a stopcock, and flushed every 4 to 6 hours with heparinized saline to maintain patency. Standard indwelling catheter care with complete dressing changes every 72 hours is recommended. When drainage becomes minimal (<25 mL/day) and echocardiography shows no recurrent effusion, the pigtail catheter can be removed. For completely drained pericardial effusions, the risk of recurrence is low (<10%) with the exception of certain etiologies (e.g., bacterial infection, malignancy).

Suggested Readings

Appleton C.P., Hatle L.K., Popp R.L. Cardiac tamponade and pericardial effusion: respiratory variation in transvalvular flow velocities studied by Doppler echocardiography. J Am Coll Cardiol. 1988;11:1020–1030.

Atar S., Chiu J., Forrester J.S., et al. Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s? Chest. 1999;116:1564–1569.

Campbell P.T., Van Trigt P., Wall T.C., et al. Subxyphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy. Chest. 1992;101:938–943.

Duvernoy O., Borowiec J., Helmius G., et al. Complications of percutaneous pericardiocentesis under fluoroscopic guidance. Acta Radiol. 1992;33:309–313.

Galli M., Politi A., Pedretti F., et al. Percutaneous balloon pericardiotomy for malignant pericardial tamponade. Chest. 1995;108:1499–1501.

Holmes D.R., Nishimura, Fountain R., et al. Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era. JACC Cardiovasc Interv. 2009;2:705–717.

Isselbacher E.M., Cigarroa J.E., Eagle K.A. Cardiac tamponade complicating proximal aortic dissection: is pericardiocentesis harmful? Circulation. 1994;90:2375–2378.

Kopecky S.L., Callahan J.A., Tajik A.J., et al. Percutaneous pericardial catheter drainage: report of 42 consecutive cases. Am J Cardiol. 1986;58:633–635.

Little W.C., Freeman G.L. Pericardial disease. Circulation. 2006;113:1622–1632.

Maisch B., Seferović P.M., Ristić A.D., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; the Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2004;25:587–610.

Markiewicz W., Borovik R., Ecker S. Cardiac tamponade in medical patients: treatment and prognosis in the echocardiographic era. Am Heart J. 1986;111:1138–1142.

Meltser H., Kalaria V.G. Cardiac tamponade. Catheter Cardiovasc Interv. 2005;64:245–255.

Tsang T.S., Enriquez-Sarano M., Freeman W.K., et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77:429–436.

Tsang T.S., Freeman W.K., Barnes M.E., et al. Rescue echocardiographically guided pericardiocentesis for cardiac perforation complicating catheter-based procedures. The Mayo Clinic experience. J Am Coll Cardiol. 1998;32:1345–1350.

Tsang T.S., Freeman W.K., Sinak L.J., et al. Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique. Mayo Clin Proc. 1998;73:647–652.

Wolfe M.W., Edelman E.R. Transient systolic dysfunction after relief of cardiac tamponade. Ann Intern Med. 1993;119:42–44.

Ziskind A.A., Pearce A.C., Lemmon C.C., et al. Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases. J Am Coll Cardiol. 1993;21:1–5.